Serenova A/S: Financial statements 2023
CVR: 30532228
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Serenova A/S (CVR 30532228) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -174,616 and a net result of DKK 63,494,947 compared with DKK 6,865,958 the year before. Equity in the 2023 report amounted to DKK 91,016,051. The solvency ratio was 93.4%.
- Gross Profit
- DKK -174,616
- Profit/Loss
- DKK 63,494,947
- Equity
- DKK 91,016,051
- Total Assets
- DKK 97,432,118
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -175K | 63.5M | 91M | 0 |
| 2022 | - | -202K | 6.9M | 27.5M | 1 |
| 2021 | - | -44K | 12.9M | 20.7M | 1 |
| 2020 | - | -54K | -83.2M | 7.8M | 1 |
| 2019 | - | -36K | -128.5M | 91M | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Serenova A/S has published its annual report for 2022. Gross profit came to DKK -201,655, and the net result was DKK 6,865,958.
About Serenova A/S
Serenova A/S is a Danish company of the type Aktieselskab based in Solrød Strand, founded in 2008. The company is in liquidation. The company is registered under the industry Ikke-finansielle holdingselskaber. The company was previously named SERENDEX PHARMACEUTICALS A/S and SERENDEX A/S. The management consists of Michael Aslo-Petersen. The company is owned by Sorana Holding A/S. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -167,993 and a net result of DKK 38,663,045 compared with DKK -24,273,688 the year before. Equity in the 2025 report amounted to DKK 105,405,408.